Biomarkers of latent TB infection

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Biomarkers of latent TB infection. / Ruhwald, Morten; Ravn, Pernille.

I: Expert Review of Respiratory Medicine, Bind 3, Nr. 4, 2009, s. 387-401.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ruhwald, M & Ravn, P 2009, 'Biomarkers of latent TB infection', Expert Review of Respiratory Medicine, bind 3, nr. 4, s. 387-401. https://doi.org/10.1586/ers.09.31

APA

Ruhwald, M., & Ravn, P. (2009). Biomarkers of latent TB infection. Expert Review of Respiratory Medicine, 3(4), 387-401. https://doi.org/10.1586/ers.09.31

Vancouver

Ruhwald M, Ravn P. Biomarkers of latent TB infection. Expert Review of Respiratory Medicine. 2009;3(4):387-401. https://doi.org/10.1586/ers.09.31

Author

Ruhwald, Morten ; Ravn, Pernille. / Biomarkers of latent TB infection. I: Expert Review of Respiratory Medicine. 2009 ; Bind 3, Nr. 4. s. 387-401.

Bibtex

@article{519b1450835911df928f000ea68e967b,
title = "Biomarkers of latent TB infection",
abstract = "For the last 100 years, the tuberculin skin test (TST) has been the only diagnostic tool available for latent TB infection (LTBI) and no biomarker per se is available to diagnose the presence of LTBI. With the introduction of M. tuberculosis-specific IFN-gamma release assays (IGRAs), a new area of in vitro immunodiagnostic tests for LTBI based on biomarker readout has become a reality. In this review, we discuss existing evidence on the clinical usefulness of IGRAs and the indefinite number of potential new biomarkers that can be used to improve diagnosis of latent TB infection. We also present early data suggesting that the monocyte-derived chemokine inducible protein-10 may be useful as a novel biomarker for the immunodiagnosis of latent TB infection.",
author = "Morten Ruhwald and Pernille Ravn",
year = "2009",
doi = "10.1586/ers.09.31",
language = "English",
volume = "3",
pages = "387--401",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Biomarkers of latent TB infection

AU - Ruhwald, Morten

AU - Ravn, Pernille

PY - 2009

Y1 - 2009

N2 - For the last 100 years, the tuberculin skin test (TST) has been the only diagnostic tool available for latent TB infection (LTBI) and no biomarker per se is available to diagnose the presence of LTBI. With the introduction of M. tuberculosis-specific IFN-gamma release assays (IGRAs), a new area of in vitro immunodiagnostic tests for LTBI based on biomarker readout has become a reality. In this review, we discuss existing evidence on the clinical usefulness of IGRAs and the indefinite number of potential new biomarkers that can be used to improve diagnosis of latent TB infection. We also present early data suggesting that the monocyte-derived chemokine inducible protein-10 may be useful as a novel biomarker for the immunodiagnosis of latent TB infection.

AB - For the last 100 years, the tuberculin skin test (TST) has been the only diagnostic tool available for latent TB infection (LTBI) and no biomarker per se is available to diagnose the presence of LTBI. With the introduction of M. tuberculosis-specific IFN-gamma release assays (IGRAs), a new area of in vitro immunodiagnostic tests for LTBI based on biomarker readout has become a reality. In this review, we discuss existing evidence on the clinical usefulness of IGRAs and the indefinite number of potential new biomarkers that can be used to improve diagnosis of latent TB infection. We also present early data suggesting that the monocyte-derived chemokine inducible protein-10 may be useful as a novel biomarker for the immunodiagnosis of latent TB infection.

U2 - 10.1586/ers.09.31

DO - 10.1586/ers.09.31

M3 - Journal article

C2 - 20477330

VL - 3

SP - 387

EP - 401

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 4

ER -

ID: 20571482